SGA
CVAC

Sector Gamma AS’s CureVac CVAC Stock Holding History

Sector Gamma AS’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-25,000
Closed -$2.29M – 39
2021
Q1 		$2.29M Buy
+25,000
New +$2.43M 0.42% 33

Other funds holding CVAC

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sector Gamma AS's CVAC Position: Q2 2021 in Review

Sector Gamma AS sold out of CureVac (CVAC) in Q2 2021, closing a stake of 25,000 shares — an estimated $2.29M sold.

Sector Gamma AS first reported a position in CVAC in Q1 2021 and held it in 1 quarter. The position peaked at $2.29M in Q1 2021. 109 funds tracked by Wall St. Rank hold CVAC as of Q2 2021.

  • Sector Gamma AS reported no remaining CureVac position as of Q2 2021 after selling out during the quarter.
  • Sector Gamma AS sold 25,000 CureVac shares in Q2 2021, an estimated $2.29M.
  • Sector Gamma AS first reported a position in CureVac in Q1 2021 and held it in 1 quarter.
  • Sector Gamma AS's CureVac position peaked at $2.29M in Q1 2021.
  • 109 funds tracked by Wall St. Rank held CureVac as of Q2 2021.

Based on Sector Gamma AS's 13F filing for Q2 2021, filed 4 Aug 2021.